KRAS and cancer: The let-7 miRNA family, which was the first reported group of TSmiRNAs in cancer, represses a number of oncogenic proteins such as KRAS, high mobility group AT-hook 2 (HMGA2), and v-myc myelocytomatosis viral oncogene homolog (MYC).